Rivaroxaban's Role in PAD Management: Where Do We Stand?

UPMC

J. Hornick

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Piedmont Heart Institute

A. Klein

Perioperative Management of Anticoagulants: Podiatry Education Series

Michigan Medicine - Podiatry

M. Munson

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis

Why Every Physician Must Diagnose Peripheral Artery Disease? How Can…

American Heart & Vascular Institute

S. Khan

Bridging the PAD Gap: A Collaborative Approach to Improving Peripher…

McMaster University Department of Medicine

R. Joseph

Risk Factors and Medical Management of PAD

Jefferson Health

T. Galanis

PAD and Endovascular Intervention

Complex Coronary Cases

V. Kapur

Clot Chronicles: Peripheral Artery Disease — What Clinicians Should …

The North American Thrombosis Forum (NATF)

M. Mcdermott

Biggest Vascular Papers/Presentations of 2022-2023

ARCH Advanced Revascularization Symposium

C. Walker

Cervical Artery Dissection: Diagnosis, Treatment and Outcomes Panel …

World Stroke Organization

V. Pujol Lereis, S. Salehi Omran, S. Yaghi, S. Engelter, H. Markus

Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Neal Kl…

Houston Methodist DeBakey Heart and Vascular Center

N. Kleiman

Novel Antithrombotics and Antiplatelets in the Treatment of PAD

Marc Bonaca

Anti-platelets in Primary and Secondary Prevention

1st Annual Heart of Prevention Symposium

C. Kliger

PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is th…

Cardiometabolic Health Congress (CMHC)

D. Bhatt

ICU Management for COVID 19 Patients: What Are the Anticoagulation S…

37th Annual Advances in Heart Disease

A. Gomez, P. Hsue

VOYAGER PAD Trial: Protecting the Patient Undergoing Lower Extremity…

Marc Bonaca